Safety of furazolidone-containing regimen in Helicobacter pylori infection: a systematic review and meta-analysis

• Published in: BMJ open Vol. 10; no. 10; p. e037375
• Main Authors: Ji, Chao-ran, Liu, Jing, Li, Yue-yue, Guo, Chuan-guo, Qu, Jun-yan, Zhang, Yan, Zuo, Xiuli
• Format: Journal Article
• Language: English
• Published: England British Medical Journal Publishing Group 19.10.2020; BMJ Publishing Group LTD; BMJ Publishing Group
• Series: Original research
• Subjects: Academic grading; Anti-Bacterial Agents - adverse effects; Antibiotics; Bias; Drug dosages; Drug resistance; Drug Therapy, Combination; Furazolidone - adverse effects; gastroenterology; Gastroenterology and Hepatology; gastrointestinal infections; health & safety; Helicobacter Infections - drug therapy; Helicobacter pylori; Human error; Humans; Industrialized nations; Infections; Meta-analysis; Software; Systematic review; Denmark; gastrointestinal infections; health & safety; gastroenterology

ObjectivesFurazolidone containing regimen is effectivefor Helicobacter pylori (H. pylori) infection, but its safetyremains controversial. To assess the safety of furazolidone containing regimenin H. pylori infection.DesignA systematic review and meta-analysis.Data sourcesPubMed, Embase, Cochrane Lib...